台湾偏头痛患者治疗模式与医疗资源利用数据表
基于台湾全民健康保险研究数据库的偏头痛治疗模式与医疗资源利用数据表,涵盖312,718例患者的用药和费用信息。

基本信息
资源简介
台湾偏头痛患者治疗模式与医疗资源利用数据表
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 781.85 KB,主题涵盖 chronic migraine、episodic migraine、real-world、Taiwan、health care resource use,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Data_Sheet_1_Treatment pattern and health care resource utilization for Taiwanese patients with migraine: a population-based study.DOCX》。配套论文《Prevalence of Migraine in Taipei, Taiwan: A Population-Based Survey》发表于 Cephalalgia(2000),DOI:10.1046/j.1468-2982.2000.00085.x。源站首次发布:2023-08-16。
【数据内容】
源站原始描述:ObjectivesGiven the substantial disease burden, appropriate and effective management of migraine is a public health priority. To gain insights into real-world migraine management practices in Taiwan, current treatment patterns, costs, and health care resource use were assessed. MethodsThis was a retrospective, longitudinal study using the Taiwan National Health Insurance Research Database. Included patients had an initial diagnosis of migraine (defined using International Classification of Disea…
【数据结构与技术规格】
文件数 1 个,合计 781.85 KB。Data_Sheet_1_Treatment pattern and health care resource utilization for Taiwanese patients with migraine: a population-based study.DOCX:undefined,781.85 KB。数据集 DOI:10.3389/fneur.2023.1222912.s001。
【主题与分类】
源站学科分类:Neurology and Neuromuscular Diseases、Neurogenetics。主题标签:chronic migraine、episodic migraine、real-world、Taiwan、health care resource use、acute medication、preventive medication。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Treatment_pattern_and_health_care_resource_utilization_for_Taiwanese_patients_with_migraine_a_population-based_study_DOCX/23962221
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Wang, Yen-Feng; Wang, Shuu-Jiun; Huang, Yao Hsien; Chen, Yung-Tai; Yen, Yu-Chun; Shia, Ben-Chang; et al. (2023). Data_Sheet_1_Treatment pattern and health care resource utilization for Taiwanese patients with migraine: a population-based study.DOCX. Frontiers. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Data_Sheet_1_Treatment pattern and health care resource utilization for Taiwanese patients with migraine: a population-based study.DOCX
- DOI:10.3389/fneur.2023.1222912.s001
- 发布日期:2023-08-16
- 文件数:1 个
- 文件总体积:781.85 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Treatment_pattern_and_health_care_resource_utilization_for_Taiwanese_patients_with_migraine_a_population-based_study_DOCX/23962221
命令行下载
curl -L -o "Data_Sheet_1_Treatment pattern and health care resource utilization for Taiwanese patients with migraine: a population-based study.DOCX" "https://ndownloader.figshare.com/files/42015405"
文件清单
Data_Sheet_1_Treatment pattern and health care resource utilization for Taiwanese patients with migraine: a population-based study.DOCX(781.85 KB)
文件总体积 781.85 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
ObjectivesGiven the substantial disease burden, appropriate and effective management of migraine is a public health priority. To gain insights into real-world migraine management practices in Taiwan, current treatment patterns, costs, and health care resource use were assessed.
MethodsThis was a retrospective, longitudinal study using the Taiwan National Health Insurance Research Database. Included patients had an initial diagnosis of migraine (defined using International Classification of Diseases codes) between 1 January 2013 and 31 December 2017. Data analyzed included demographics; the use, number, and type of acute and preventive medications; and drug and medical services costs. Data were stratified according to migraine type (chronic [CM] or episodic [EM] migraine).
ResultsA total of 312,718 patients were included in the analyses: 53,992 (17.3%) had CM and 258,726 (82.7%) had EM. Most patients (81.7%) had used acute and/or preventive medications; acute medications used more frequently than preventive medications (78.0% vs. 20.2%). Acute medications were used by 81.6 and 77.3% of patients with CM and EM, respectively. Commonly used acute medications were acetaminophen (68.8%), ergots (49.4%), and non-steroidal anti-inflammatory drugs (38.4%); the use of triptans (6.0%), tramadol (3.1%), and other opioids (0.2%) was less common. A total of 28.6 and 18.5% of patients with CM and EM, respectively, used preventive medications. Flunarizine (68.9%), propranolol (40.7%), and topiramate (16.0%) were the most commonly used preventive medications. Most patients had used 1–2 acute or preventive medications, with the use of ≥3 acute or preventive medications more common in patients with CM than EM. Average total medical cost per annum was 4,169 New Taiwan Dollars (NTDs) per CM patient and 2,928 NTDs per EM patient, with CM patients having higher costs associated with medical service utilization and acute medication use.
ConclusionThese real-world data suggest unmet needs for Taiwanese patients with migraine, including under-utilization of preventive medications and greater costs and health care resource use for patients with CM versus EM. These findings provide importa
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fneur.2023.1222912.s001(source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Treatment_pattern_and_health_care_resource_utilization_for_Taiwanese_patients_with_migraine_a_population-based_study_DOCX/23962221)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




